Skrindo I, Farkas L, Kvale E O, Johansen F-E, Jahnsen F L
Laboratory for Immunohistochemistry and Immunopathology, Centre for Immune Regulation, Institute of Pathology, University of Oslo, Oslo, Norway.
Clin Exp Allergy. 2008 Nov;38(11):1752-9. doi: 10.1111/j.1365-2222.2008.03081.x. Epub 2008 Jul 31.
It has been suggested that allergic diseases are caused by defective suppression of allergen-specific Th2 cells by CD4(+)CD25(+) regulatory T cells. However, such studies have been hampered by the difficulty in distinguishing regulatory T cells from CD25-expressing activated T cells. Recently, it was shown that conventional T cells expressed high levels of CD127, whereas regulatory T cells were CD127(lo), allowing discrimination between these distinct T cell subpopulations.
The aim of this study was to study whether the putative regulatory subset defined as CD4(+)CD25(+)CD127(lo) was involved in grass pollen-reactive T cell responses.
Peripheral blood mononuclear cells (PBMCs) were obtained from allergic donors and non-atopic controls out of season. Grass pollen-induced cytokine production and proliferation were compared in cultures of undepleted cells and cells depleted of CD4(+)CD25(+), CD4(+)CD25(+)CD127(hi) or CD4(+)CD25(+)CD127(lo) T cells.
Undepleted cell cultures from allergic patients showed significantly increased proliferation and Th2 cytokine production compared with non-atopic controls. Depletion of all CD25(+) T cells did not increase cytokine production or proliferation, and more importantly, no increase in Th2 cytokine production or proliferation was observed in cell cultures depleted of CD4(+)CD25(+)CD127(lo) cells (putative regulatory T cells) compared with undepleted PBMCs in both the allergic and the non-atopic group.
Our study showed that T cells from grass pollen-allergic patients and non-atopic controls responded very differently to grass pollen extract, but this difference could not be explained by differences in regulatory T cell function. Further studies are needed to understand the importance of regulatory T cells in allergy.
有研究表明,过敏性疾病是由CD4(+)CD25(+)调节性T细胞对变应原特异性Th2细胞的抑制缺陷所致。然而,此类研究因难以区分调节性T细胞与表达CD25的活化T细胞而受到阻碍。最近有研究表明,传统T细胞表达高水平的CD127,而调节性T细胞的CD127表达水平较低(CD127(lo)),这使得区分这些不同的T细胞亚群成为可能。
本研究旨在探讨定义为CD4(+)CD25(+)CD127(lo)的假定调节性亚群是否参与草花粉反应性T细胞应答。
在非花粉季节从过敏性供体和非特应性对照者获取外周血单个核细胞(PBMC)。比较未去除细胞以及去除CD4(+)CD25(+)、CD4(+)CD25(+)CD127(hi)或CD4(+)CD25(+)CD127(lo) T细胞的细胞培养物中草花粉诱导的细胞因子产生和增殖情况。
与非特应性对照相比,过敏性患者的未去除细胞培养物显示出显著增加的增殖和Th2细胞因子产生。去除所有CD25(+) T细胞并未增加细胞因子产生或增殖,更重要的是,在过敏性和非特应性组中,与未去除PBMC相比,去除CD4(+)CD25(+)CD127(lo)细胞(假定调节性T细胞)的细胞培养物中未观察到Th2细胞因子产生或增殖增加。
我们的研究表明,草花粉过敏患者和非特应性对照者的T细胞对草花粉提取物的反应差异很大,但这种差异无法用调节性T细胞功能的差异来解释。需要进一步研究以了解调节性T细胞在过敏中的重要性。